The Market Is Missing UiPath's AI Reversal (Rating Upgrade)

UiPath (PATH) has received an analyst upgrade to "Buy," driven by a fundamental shift in its business model and an attractive valuation. The company's Q2 2026 results demonstrated robust performance, with revenues up 14% year-over-year to $362 million and ARR growing 11% to $1.723 billion, significantly boosted by its agentic automation and AI solutions which are expanding deal sizes and customer engagement. This, combined with substantial operating leverage leading to a 9.5x increase in adjusted EBIT and strong customer retention, suggests a more profitable growth trajectory, with the analyst projecting over 60% upside to a $22.9 price target based on revised earnings expectations.

Analysis

UiPath (PATH) has received an analyst upgrade to "Buy," citing a fundamental shift driven by agentic automation and AI solutions. Q2 2026 revenues grew 14% YoY to $362 million, beating consensus by over 4%, with ARR up 11% to $1.723 billion. Management highlights AI's role in expanding deal sizes and engaging 450 customers in AI agent development, evidenced by nearly 1 million agent runs.

The company exhibits significant operating leverage, with adjusted gross profit margin rising to 84% and adjusted EBIT increasing 9.5x in Q2 2026, despite contracting OPEX. Strong dollar-based gross retention at 98% and net retention at 108% underscore robust customer loyalty and expansion, enhancing earnings visibility.

Long-term EPS consensus estimates have doubled, reflecting the improved outlook. Management guided Q3 2026 sales to $390-395 million and non-GAAP EBIT to $70 million, projecting a 12-13% QoQ increase. Share repurchases of 8.3 million shares at $12.10 further support shareholder value, with the analyst projecting a 60% upside to a $22.9 price target based on a 25-26x FY2027 P/E.

Key risks include the execution of the agentic automation strategy, as the 1 million agent runs may still represent pilot activity rather than scaled deployment. The bullish EPS estimates rely on assumptions that may not fully materialize, and failure to scale could lead to multiple contraction.

Key Decisions for Investors

• Consider initiating or increasing long positions in PATH, given the analyst's "Buy" upgrade, strong Q2 2026 performance, and significant operating leverage.
• Monitor the scaling of UiPath's agentic automation solutions and customer adoption, as execution risk remains a key factor for achieving projected earnings growth and valuation.
• Evaluate upcoming Q3 2026 earnings for further confirmation of management's guidance and the impact of share repurchases, which could act as a catalyst for stock appreciation.